Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mckesson Corp (MCK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,155,552
  • Shares Outstanding, K 201,780
  • Annual Sales, $ 208,357 M
  • Annual Income, $ 67,000 K
  • 36-Month Beta 1.29
  • Price/Sales 0.13
  • Price/Cash Flow 4.81
  • Price/Book 2.78

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.43 +2.50%
on 06/28/18
149.43 -9.85%
on 06/22/18
-11.33 (-7.76%)
since 06/18/18
3-Month
131.43 +2.50%
on 06/28/18
160.84 -16.25%
on 04/30/18
-14.57 (-9.76%)
since 04/18/18
52-Week
131.43 +2.50%
on 06/28/18
178.86 -24.68%
on 01/29/18
-30.70 (-18.56%)
since 07/18/17

Most Recent Stories

More News
San Francisco to consider tax on companies to help homeless

SAN FRANCISCO (AP) — San Francisco voters will decide in November whether to tax large businesses to pay for homeless and housing services, an issue that set off a battle in another West Coast city struggling...

MCK : 134.95 (+0.27%)
CRM : 146.62 (-0.27%)
McKesson Applauds DOJ Policy Change on Opioid Quotas

McKesson Corporation today praised the U.S. Department of Justice's decision to exercise its authority to reduce opioid production if the agency believes a particular drug is highly diverted....

MCK : 134.95 (+0.27%)
Will 5 Elements Drive Quest Diagnostics (DGX) Q2 Earnings?

Per Quest Diagnostics (DGX), growing strength of partnerships with health care leaders and strategic acquisitions are creating growth prospects for the top and bottom-line growth.

SYK : 175.31 (-0.45%)
DGX : 113.85 (-0.18%)
MCK : 134.95 (+0.27%)
RMD : 109.10 (-0.26%)
Can Established Pharmaceuticals Up Abbott (ABT) Q2 Earnings?

According to Abbott (ABT), key emerging markets represent the most attractive long-term growth opportunities for its branded generics product portfolio within EPD.

ABT : 64.79 (+3.17%)
SYK : 175.31 (-0.45%)
MCK : 134.95 (+0.27%)
RMD : 109.10 (-0.26%)
Mckesson Corp Set to Possibly Rebound After Yesterday's Selloff of 2.23%

Mckesson Corp (NYSE:MCK) traded in a range yesterday that spanned from a low of $133.96 to a high of $137.17. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $135.80...

MCK : 134.95 (+0.27%)
Look for Shares of Mckesson Corp to Potentially Rebound after Yesterday's 2.23% Sell Off

Mckesson Corp (NYSE:MCK) traded in a range yesterday that spanned from a low of $133.96 to a high of $137.17. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $135.80...

MCK : 134.95 (+0.27%)
Can Abbott (ABT) Rise on Robust Overall Growth in Q2 Earnings?

Abbott (ABT) gains traction from a steady healthy growth trajectory seen in core Diabetes Care business.

ABT : 64.79 (+3.17%)
SYK : 175.31 (-0.45%)
MCK : 134.95 (+0.27%)
RMD : 109.10 (-0.26%)
Will Flagship Impella Drive Abiomed's (ABMD) Q1 Earnings?

Abiomed's (ABMD) first-quarter fiscal 2019 earnings are likely to be driven by an exclusive Impella product line. Intense competition raises concern.

MCK : 134.95 (+0.27%)
VAR : 116.75 (+0.62%)
ABMD : 428.09 (+0.17%)
BDX : 246.46 (-0.52%)
Can International Sales Drive Baxter's (BAX) Q2 Earnings?

Baxter's (BAX) Q2 earnings likely to be aided by promising international ventures and acquisitions; cyclophosphamide competition raises concern.

MCK : 134.95 (+0.27%)
VAR : 116.75 (+0.62%)
BDX : 246.46 (-0.52%)
BAX : 74.70 (-0.07%)
Will Core Distribution Unit Aid McKesson (MCK) Q1 Earnings?

Strong prospects in the Distribution Solutions segment is likely to boost McKesson's (MCK) top-line performance in the fiscal first quarter.

ABC : 86.68 (-0.16%)
MCK : 134.95 (+0.27%)
BIO : 300.67 (-0.64%)
DVA : 70.59 (-1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade MCK with:

Business Summary

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare...

See More

Key Turning Points

2nd Resistance Point 136.55
1st Resistance Point 135.57
Last Price 134.95
1st Support Level 134.01
2nd Support Level 133.43

See More

52-Week High 178.86
Fibonacci 61.8% 160.74
Fibonacci 50% 155.14
Fibonacci 38.2% 149.55
Last Price 134.95
52-Week Low 131.43

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar